These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4740207)

  • 1. [Pharmacokinetic studies on azapropazone in animals].
    Jahn U; Reller J; Schatz F
    Arzneimittelforschung; 1973 May; 23(5):660-6. PubMed ID: 4740207
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetic studies on 14C-azapropazone dihydrate in the rat].
    Klatt L; Koss FW
    Arzneimittelforschung; 1973 Jul; 23(7):913-9. PubMed ID: 4800443
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetic studies on 14C-azapropazone dihydrate in man].
    Klatt L; Koss FW
    Arzneimittelforschung; 1973 Jul; 23(7):920-1. PubMed ID: 4800444
    [No Abstract]   [Full Text] [Related]  

  • 4. Absorption, excretion and metabolism of a new analgesic and anti-inflammatory drug K 4277 in rats, guinea pigs, rabbits and dogs.
    Goldaniga GC; Pianezzola E; Valzelli G
    Arzneimittelforschung; 1974 Oct; 24(10):1603-6. PubMed ID: 4479768
    [No Abstract]   [Full Text] [Related]  

  • 5. [Toxicologic studies on the effect of azapropazone on reproduction in the rat].
    Adrian RW
    Arzneimittelforschung; 1973 May; 23(5):658-60. PubMed ID: 4740206
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of 6-chloro-5-cyclohexylindane-1-carboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent. 3. Species differences in metabolism.
    Tanayama S
    Xenobiotica; 1973 Oct; 3(10):671-80. PubMed ID: 4774633
    [No Abstract]   [Full Text] [Related]  

  • 7. [NMR studies on the molecular structure of azapropazone and interpretation of its pharmacokinetics and biotransformation].
    Fenner H; Mixich G
    Arzneimittelforschung; 1973 May; 23(5):667-9. PubMed ID: 4740209
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Serum levels and urinary excretion in rats, rabbits and dogs.
    Coppi G; Bonardi G; Perego R
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:234-6. PubMed ID: 5067199
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of rheumatic diseases with Azapropazon suppositories].
    Beckschäfter W
    Schweiz Rundsch Med Prax; 1971 Apr; 60(14):447-8. PubMed ID: 5314614
    [No Abstract]   [Full Text] [Related]  

  • 10. Disposition and metabolism of fenbufen in several laboratory animals.
    Chiccarelli FS; Eisner HJ; Van Lear GE
    Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioxoisoquinoline-4-carboxanilides, novel nonsteroidal anti-inflammatory agents with a species-specific effect on basal metabolism.
    Wiseman EH; Gralla EJ; Chiaini J; Migliardi JR; Chang YH
    J Pharmacol Exp Ther; 1970 Mar; 172(1):138-53. PubMed ID: 4190453
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical efficacy of the new anti-inflammatory agent Azapropazone].
    Sausgruber H
    Arzneimittelforschung; 1971 Aug; 21(8):1230-4. PubMed ID: 4938489
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemical studies on acemetacin/Experimental tests in animals (author's transl)].
    Dell HD; Doersing M; Fischer W; Jacobi H; Kamp R
    Arzneimittelforschung; 1980; 30(8A):1371-83. PubMed ID: 7191304
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological behavior: serum levels, excretion and biotransformation of (3-benzoylphenyl)-2-propionic acid, or ketoprofen, in animals and men].
    Populaire P; Terlain B; Pascal S; Decouvelaere B; Renard A; Thomas JP
    Ann Pharm Fr; 1973 Dec; 31(12):735-49. PubMed ID: 4804224
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic patterns of 4-allyloxy-3-chlorophenylacetic acid in rat, rabbit, dog, monkey, and man.
    Roncucci R; Simon MJ; Lambelin G; Gillet C; Staquet M; Buu-Hoï NP
    Arzneimittelforschung; 1970 May; 20(5):631-6. PubMed ID: 4987566
    [No Abstract]   [Full Text] [Related]  

  • 16. Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man.
    Hucker HB; Stauffer SC; White SD; Rhodes RE; Arison BH; Umbenhauer ER; Bower RJ; McMahon FG
    Drug Metab Dispos; 1973; 1(6):721-36. PubMed ID: 4156293
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the absorption and elimination of benzydamine in the mouse, rat, dog, and man.
    Catanese B; Grasso A; Silverstrini B
    Arzneimittelforschung; 1966 Oct; 16(10):1354-7. PubMed ID: 6014929
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of inhibitors in studies of comparative enzymology.
    Hitchings GH
    Fed Proc; 1967; 26(4):1078-81. PubMed ID: 6028773
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of the Mizushima test (Mt) for the evaluation of antirheumatics].
    Wagner-Jauregg T
    Int J Clin Pharmacol; 1972 Nov; 6(4):391-6. PubMed ID: 4629828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.